SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis

SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis

Coronary heart disease is a narrowing or obstruction of the vascular cavity caused by atherosclerosis of the coronary arteries, which leads to myocardial ischemia and hypoxia. At present, percutaneous coronary intervention (PCI) is an effective treatment for coronary atherosclerotic heart disease. R...

Full description

Bibliographic Details
Main Authors:	Qing Zhang, Zhiwen Deng, Tudi Li, Kaitong Chen, Zhihuan Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	SGLT2 inhibitor restenosis coronary heart disease AMI—acute myocardial infarction ASCVD-atherosclerotic cardiovascular disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1280547/full

Similar Items

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Erkan Yıldırım, et al.
Published: (2017-12-01)

The problem ofpreventing vascular restenosis after implantation of a coronary stent
by: А В Sumarokov, et al.
Published: (2004-08-01)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
by: Waseem Raja, et al.
Published: (2020-12-01)

Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization
by: Zhuoxuan Yang, et al.
Published: (2023-05-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Single nucleotide polymorphism in coronary artery disease as in-stent restenosis risk factor
by: Edyta Kinga Prokop, et al.
Published: (2016-09-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
by: Mohammad Saifur Rohman, et al.
Published: (2023-07-01)

PREDICTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN OBESE WOMEN
by: N. G. Veselovskaya, et al.
Published: (2014-09-01)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
by: Huilin Hu, et al.
Published: (2021-11-01)

Oral Health of Patients Undergoing Percutaneous Coronary Intervention—A Possible Link between Periodontal Disease and In-Stent Restenosis
by: Ferenc Tamás Nagy, et al.
Published: (2023-04-01)

SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes
by: Raffaele Marfella, et al.
Published: (2023-02-01)

RISK FACTORS OF CORONARY ARTERIES RESTENOSIS AFTER STENTING IN POSTMENOPAUSAL WOMEN WITH OBESITY
by: E. S. Osipova, et al.
Published: (2018-06-01)

High coronary calcium score and post-procedural CK-MB are noninvasive predictors of coronary stent restenosis
by: Lee JB, et al.
Published: (2017-02-01)

A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents
by: Min-Tao Gai, et al.
Published: (2021-09-01)

Coronary CT Angiography- Based Assessment of Coronary in-Stent Restenosis: A Journey through Past and Present Trends
by: Yoon Seong Lee, et al.
Published: (2024-03-01)

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review
by: AN Jingjing, WANG Xiaojuan, DENG Aiyun
Published: (2023-03-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Pathogenetic mechanism of stented coronary arteries restenosis and the role of vasculoendothelial growth factor A
by: M.P. Kopytsya, et al.
Published: (2019-10-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
by: Hongfei Xi, et al.
Published: (2023-03-01)

A case of repeated in-stent restenosis of coronary artery as a primary manifestation of seronegative antiphospholipid antibody syndrome
by: Mingqiang Fu, et al.
Published: (2024-01-01)

Correlations Between the Contrast Density Gradient along the Coronary Stents and Functional Significance of In-stent Restenosis
by: Orzan Marius, et al.
Published: (2016-06-01)

Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study
by: Ling Zhang, et al.
Published: (2021-09-01)

Coronary Artery Perforation After Balloon Dilatation for Recurrent In-Stent Restenosis Inside the Double-Layered Previous Stents
by: Daichi Yamashita, MD, PhD, et al.
Published: (2023-09-01)

Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005-10-01)

Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography
by: Ulrich Güldener, et al.
Published: (2023-04-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
by: Weihao Xue, et al.
Published: (2022-11-01)

Complications in Acute Myocardial Infarction: Navigating Challenges in Diagnosis and Management
by: Errol Moras, et al.
Published: (2024-03-01)

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review
by: Aurélie Pahud de Mortanges, et al.
Published: (2021-11-01)

Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis
by: Shiva Ganjali, et al.
Published: (2021-08-01)

Impact of Admission, Fasting Glucose and HbA1c Levels on in-stent Restenosis in The Patients Treated with Primary Percutaneous Coronary Intervention in 5-Year Follow-up
by: Fatma Özpamuk Karadeniz, et al.
Published: (2021-01-01)

SGLT2 Inhibition in Acute Myocardial Infarction—A Comprehensive Review
by: Martin Benedikt, et al.
Published: (2023-01-01)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
by: Amr Abouelnour, et al.
Published: (2022-08-01)

Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis
by: Yuan Fu, et al.
Published: (2022-08-01)

SYSTEMATIC CHARACTERIZATION OF CAUSES OF RESTENOSIS IN PATIENTS WITH CORONARY ANGIOPLASTY
by: Storozhuk N. V., et al.
Published: (2018-11-01)

Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience
by: Anis Ghariani, et al.
Published: (2022-05-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
by: Annalisa Capuano, et al.
Published: (2022-11-01)

Ten-year atherosclerosis cardiovascular disease (ASCVD) risk score and its components among an Iranian population: a cohort-based cross-sectional study
by: Fatemeh Zibaeenejad, et al.
Published: (2022-04-01)

Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
by: Priyanka Satish, et al.
Published: (2021-09-01)